Bayer CropScience Ltd (BAYERCROP) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Bayer CropScience Ltd on NSE and BSE, with an AI summary of each filing.
Please find attached herewith a copy of News Release that is being issued by the Company today.
Press Release · 04 Nov 2026, 12:50 am
Bayer CropScience Reports Q2 FY26-27 Results and Declares ₹90 Interim Dividend For Q2 ended 30th Sep'26, Bayer CropScience posted revenue of ₹12,507 million, down 19% YoY, hit by uneven monsoons and lower corn acreage. However, PBT rose 6% YoY to ₹2,114 million and PAT increased 9% YoY, driven by higher gross margins from corn seed yields and cost efficiencies. For H1 ended 30th Sep'26, revenue declined 11% YoY to ₹30,857 million, while PBT grew 15% YoY to ₹6,135 million. The Board declared an interim dividend of ₹90 per equity share, totaling ₹4,045 million.
Pursuant to Regulation 30 of SEBI LODR Regulations 2015, please be informed that the Board of Directors at the board meeting held on November 30, 2026 took note of the resignation by a ....
Change in Management · 04 Nov 2026, 12:46 am
Bayer CropScience Announces Board Changes and Senior Management Resignation Bayer CropScience announced leadership changes approved at its Board meeting on 3rd Nov'26. Dr. Thomas Hoffmann will resign as Non-Executive Non-Independent Director effective 30th Nov'26 due to expanded responsibilities at Bayer AG. Ms. Christiane Temminghoff has been appointed as an Additional Director (Non-Executive Non-Independent) effective 1st Dec'26, subject to shareholder approval. Additionally, Mr. Rajaram Mohan Babu Boppana, Cluster Commercial Lead and Senior Management Personnel, resigned effective 31st Dec'26 to pursue external opportunities.
Pursuant to Regulation 30 of SEBI LODR Regulations 2015, please be informed that the Board of Directors at the meeting held on November 03, 2026 took note of the changes in Directors.
Change in Management · 04 Nov 2026, 12:42 am
Bayer CropScience Announces Board and Senior Management Changes Bayer CropScience Limited approved key leadership changes on 3rd Nov'26. Dr. Thomas Hoffmann will step down as Non-Executive and Non-Independent Director effective 30th Nov'26 due to expanded responsibilities at Bayer AG. The board appointed Ms. Christiane Temminghoff as an Additional Director (Non-Executive, Non-Independent) effective 1st Dec'26, subject to shareholder approval. Additionally, Mr. Rajaram Mohan Babu Boppana resigned as Cluster Commercial Lead and Senior Management Personnel, effective 31st Dec'26, to pursue an external career opportunity.
We hereby inform you that the Board of Directors of the Company at their Meeting held on November 03, 2026, declared an Interim Dividend of Rs. 90/- per equity share of Rs. 10/- each for ....
Dividend · 04 Nov 2026, 12:33 am
Bayer CropScience Declares Interim Dividend of Rs. 90 Per Share for FY27 Bayer CropScience Limited declared an interim dividend of Rs. 90 per equity share (face value of Rs. 10 each) for FY26-27 during its board meeting held on 3rd Nov'26. The company has fixed the record date as Thursday, 12th Nov'26, to determine eligible shareholders. The interim dividend will be paid on Monday, 30th Nov'26.
Pursuant to Regulation 30 of SEBI LODR Regulation 2015, we would like to inform you that the Board of Directors at their meeting held today, i.e. November 03, 2026, has inter alia approved ....
Dividend · 04 Nov 2026, 12:27 am
Bayer CropScience Q2 FY27 Results: PAT Rises YoY; Rs 90 Dividend Declared Bayer CropScience reported revenue from operations of Rs 12,507m for Q2 ended 30th Sep'26, down 19.5% YoY from Rs 15,534m and down 31.8% QoQ. Profit before tax stood at Rs 2,114m versus Rs 2,003m in Q2 FY26. Net profit rose 8.8% YoY to Rs 1,662m from Rs 1,527m, yielding an EPS of Rs 36.98. For H1 FY27, revenue reached Rs 30,857m with net profit at Rs 4,878m. The Board declared an interim dividend of Rs 90 per equity share (record date: 12th Nov'26, payment date: 30th Nov'26).
Pursuant to Regulation 30 of SEBI LODR Regulations 2015, we would like to inform you that the Board of Directors at their meeting today , i.e. November 03, 2026, has inter alia approved ....
Financial Result · 04 Nov 2026, 12:20 am
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of ....
Outcome · 04 Nov 2026, 12:01 am
Bayer CropScience Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 12,507 (-19.5% YoY | -31.8% QoQ) ■ EBITDA: 2,177 (+6.0% YoY | -40.8% QoQ) ■ EBITDA Margin (%): 17.4 (+419 bps YoY | -263 bps QoQ) ■ PAT: 1,662 (+8.8% YoY | -48.3% QoQ) ■ EPS (INR): 37.0 (+8.8% YoY | -48.3% QoQ)
Pursuant to Regulation 30 of SEBI Listing Regulations 2015 we hereby inform you about the resignation of Mr. Rajaram Mohan Babu Boppana as the SMP of the Company.
Change in Management · 23 Oct 2026, 10:59 pm
Bayer CropScience SMP Rajaram Mohan Babu Boppana Resigns Bayer CropScience Limited announced that Rajaram Mohan Babu Boppana, Cluster Commercial Lead and Senior Management Personnel (SMP), has resigned from the company to pursue an external career opportunity. His resignation will take effect at the close of business hours on 31st Dec'26, upon which he will formally step down from his SMP role. The company confirmed there are no other material reasons behind his departure.
Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Pursuant to SEBI Listing ....
Intimation · 03 Nov 2026, 5:30 am
Bayer CropScience Schedules Board Meeting for Q2 Results and Interim Dividend Bayer CropScience Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to review and approve the unaudited financial results for the quarter ended 30th Sep'26. Additionally, the Board will consider the declaration of an interim dividend for FY26-27 and fix the record date for the payout. In compliance with insider trading regulations, the company's trading window remains closed for all designated persons.
Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, read with Schedule III of the Listing Regulations & SEBI Master Circular dated January 30, 2026, we hereby attach intimation regarding ....
Others (Uncategorized) · 01 Sept 2026, 10:44 pm
Bayer CropScience Receives Unsolicited ESG Rating from Crisil On 01 Sep'26, Bayer CropScience (BAYERCROP) announced it has received an ESG rating from Crisil ESG Ratings and Analytics. The company was assigned an overall "Crisil ESG 66" and a "Crisil Core ESG 70". These ratings were assigned independently by Crisil based on publicly available information, as Bayer confirmed it had not engaged the rating agency for this purpose. The rating reflects an assessment of the company's standalone Environmental, Social, and Governance parameters based on public disclosures.
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, we wish to inform you the Company''s representative will participate in Ashwamedh Elara India Dialogue 2026 on 2nd September, 2026.
Intimation · 26 Aug 2026, 9:37 pm
Bayer CropScience to Participate in Ashwamedh Elara India Dialogue 2026 Bayer CropScience (BAYERCROP) announced its participation in the Ashwamedh Elara India Dialogue 2026. Company representatives will engage with analysts and institutional investors on 02 Sep'26, from 10:00 am to 11:00 am. The company explicitly stated that no unpublished price-sensitive information will be disclosed during the meeting. Participation is subject to change due to any exigencies from the organizer or the company.
Disclosure of the voting results of the 68th AGM of the Company along with scrutinizer''s report.
Annual General Meeting · 20 Aug 2026, 12:12 am
Pursuant to Regulation 30 of SEBI Listing Regulations, 2015, please find attached summary of proceedings/outcome of 68th AGM of the Company held on August 19, 2026 through VC/OAVM.
Annual General Meeting · 20 Aug 2026, 12:07 am
We herewith attach a copy of Press Release being issued by the Company today in connection with captioned subject.
Press Release · 06 Aug 2026, 12:05 am
Bayer CropScience Q1FY27 PBT Rises 20% Despite Revenue Dip Bayer CropScience reported a 4% YoY decline in Revenue from Operations to ₹18,350 million for Q1FY27, ended Jun 30, '26. Despite lower revenue, Profit Before Tax (PBT) grew 20% YoY to ₹4,021 million, supported by improved gross margins from favorable pricing and a stronger product mix. The quarter also included a one-time income of ₹639 million from divesting marketing rights for formulated products. Profit After Tax increased by 15%. Management cited challenging weather and market conditions for the revenue decline.
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, we wish to inform you that the Board at its meeting held on August 05, 2026 considered and approved the changes in board of directors ....
Change in Management · 05 Aug 2026, 11:53 pm
Bayer CropScience Appoints New Chairman Amid Board Transition Bayer CropScience announced leadership changes, appointing Mr. Ravi Kirpalani as an Additional Independent Director for a five-year term effective Sep 01, '26. He will succeed Mr. Pankaj Ramanbhai Patel as Chairman from Sep 12, '26, following the completion of Mr. Patel's term on Sep 11, '26. Mr. Kirpalani brings extensive leadership experience from his previous roles as MD of Castrol India and CEO of Thyssenkrupp India, along with directorships at Foseco India, Greaves Cotton, and Versuni India Home Solutions.
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Others (Uncategorized) · 24 Jul 2026, 4:39 pm
Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, 2015, the Company has sent a letter to the Shareholders of the Company providing weblink of the Annual Report for the financial ....
Annual Report · 22 Jul 2026, 6:05 pm
Attached BRSR for the Financial Year ended March 31, 2026. This also forms part of the Company''s Annual Report for the Financial Year ended March 31, 2026.
Others (Uncategorized) · 21 Jul 2026, 5:30 pm
Attached Notice of 68th Annual General Meeting of the Company scheduled on Wednesday August 19, 2026 at 11.30 a.m. IST.
Annual General Meeting · 21 Jul 2026, 5:16 pm
Attached the Annual Report for the Financial Year 2025-26.
Others (Uncategorized) · 21 Jul 2026, 5:07 pm
Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
Intimation · 05 Aug 2026, 5:30 am
Bayer CropScience Board Meeting Set for Q1 FY27 Results Bayer CropScience Ltd. has scheduled a Board of Directors meeting for 05 Aug'26 to consider and approve its unaudited financial results for the first quarter ending 30 Jun'26. The meeting will be conducted via physical or audio-visual means. In line with regulatory requirements, the company has closed its trading window for all designated persons under its insider trading policy until the results are declared. This announcement, dated 17 Jul'26, is a key procedural step ahead of the quarterly earnings release.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has received ....
Others (Uncategorized) · 15 Jul 2026, 10:47 pm
Bayer CropScience Hit with INR 22 Million GST Penalty Bayer CropScience received an order on 15 Jul'26 from the GST Commissionerate in Hyderabad imposing a penalty of INR 22 million. The penalty relates to alleged violations regarding outward supply and Input Tax Credit availed during the financial years 2020-21 to 2022-23. The company has stated that the order is appealable and it will assess its right to appeal, indicating a potential challenge to the financial liability. The monetary impact is quantified at INR 22 million, subject to the outcome of the appeal process.
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bayer AG
Others (Uncategorized) · 14 Jul 2026, 12:50 am
Bayer AG Acquires 11.91% Stake in Indian Arm via Promoter Transfer Bayer AG acquired 53,54,030 equity shares, representing an 11.91% stake in Bayer CropScience Ltd, from fellow promoter Bayer CropScience AG on 8th Jul'26. The transaction, executed via a block deal at INR 4,122.30 per share, was an inter-se transfer among the promoter group. Following the acquisition, Bayer AG's shareholding in the Indian entity increased from 8.43% to 20.34%, while Bayer CropScience AG's holding was reduced to zero. The transfer is exempt from open offer requirements under SEBI regulations.
Please find enclosed the disclosure as received by the Company pursuant to Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from our Promoters - Bayer AG ....
Others (Uncategorized) · 11 Jul 2026, 12:48 am
Bayer Promoters Execute Inter-se Share Transfer Promoter entities of Bayer CropScience Limited executed an inter-se transfer via block deals on the NSE. On 09-Jul'26, Bayer AG acquired 53,54,030 equity shares, raising its stake from 8.43% to 20.34%. Concurrently, on 10-Jul'26, Bayer CropScience AG sold 53,54,030 shares, representing its entire 11.91% holding, resulting in a nil stake post-transaction. The total value of the transaction was INR 22,070,917,869. This internal restructuring consolidates the promoter holding under Bayer AG without altering the overall promoter group shareholding.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bayer CropScience AG. & PACs
Acquisition/ Disposal of Shares · 10 Jul 2026, 8:50 pm
Bayer Promoters Execute Inter-Se Transfer of 11.91% Stake Promoter group entity Bayer CropScience AG sold 53,54,030 equity shares, representing an 11.91% stake in Bayer CropScience Ltd, to fellow promoter Bayer AG on 8th Jul'26. The transaction was conducted as an inter-se transfer via a block deal. This internal shareholding realignment among the promoter group does not alter the total promoter stake in the company. The total share capital of the target company remains 4,49,42,092 equity shares.